Epidemiology and medical management of stone disease

@article{Tiselius2003EpidemiologyAM,
  title={Epidemiology and medical management of stone disease},
  author={Hans G{\"o}ran Tiselius},
  journal={BJU International},
  year={2003},
  volume={91}
}
  • H. Tiselius
  • Published 1 May 2003
  • Medicine
  • BJU International
Recurrent stone formation in the urinary tract is a common and important problem that must be considered in daily urological practice. With a prevalence of> 10% and an expected recurrence rate of ≈ 50%, stone disease has an important effect on the healthcare system. It is generally agreed that patients with uric acid/urate, cystine or infection stones always should be treated pharmacologically. For calcium stone formers the treatment should be chosen according to the severity of the disease… 
Recurrence Prevention in Patients with Urinary Tract Stone Disease
TLDR
The principles for recurrence preventive measures in patients with uric acid, infection, cystine and calcium stone disease are summarized and Categories of stone formers are identified with the aim of providing a basis for an individualised treatment with a reasonable patient's compliance.
Establishment and Management of a Stone Clinic
The incidence of upper urinary tract stone disease has risen steadily throughout the past 100 years and renal colic is now one of the commonest causes of admission to hospital. Spontaneous passage of
Who Forms Stones and Why
Prevention of Stone Disease
TLDR
The ‘metabolic syndrome’ includes all the diseases, e.g. hypertension, lipid imbalances, type 2 diabetes mellitus, gout and cardiovascular disease, which are concomitant in the majority of stone formers.
Therapy of nephrolithiasis: where is the evidence from clinical trials?
TLDR
The available evidence on medical expulsive therapy for ureteral stones is analyzed; the evidence about non-pharmacological stone therapy including dietary modifications and citrus juice-based therapy is described; and the efficacy of thiazide diuretics for the treatment of hypercalciuria in recurrent nephrolithiasis is discussed.
Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?
TLDR
It is suggested that the improved understanding of this process can be used for a more dynamic risk evaluation and treatment regimen directed to specific risk periods that can be identified in the individual patients.
Alpha-blockers as medical expulsive therapy for ureteral stones.
BACKGROUND Urinary stone disease is one of the most common reasons for patients visiting a urology practice, affecting about 5% to 10% of the population. Annual costs for stone disease have rapidly
Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?
TLDR
It is important, however, that every preventive regimen is balanced between the effects on urine composition and patients’ tolerance to the treatment in order to achieve satisfactory compliance.
Kidney stone disease
TLDR
In the last century, as technology has continued to advance at a more rapid pace, the ability to treat nephrolithiasis has paralleled these developments.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 93 REFERENCES
Medical Prevention of Renal Stone Disease
TLDR
In patients with recurrent disease, a significant reduction in stone formation rate from pretreatment was found in the placebo group maintained on a conservative program, underscoring the importance of increased fluid intake and dietary modification.
STONE INCIDENCE AND PREVENTION
TLDR
The intention of this paper is to discuss some metabolic risk factors and preventive treatment of stone disease and to describe a few simple principles that can be followed in the clinical routine.
Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease
Numerous treatment regimens for preventing recurrent formation of calcium stones have been designed and published during recent decades. However, the results of prophylactic therapy for stone disease
Stone formation and urine composition in calcium stone formers without medical treatment.
TLDR
It is suggested that stone formation during tT and tA advantageously might be used for preliminary evaluation of the therapeutic response, as well as the risk of forming a urine highly supersaturated with calcium oxalate calculated for a 24-hour urine volume of 1,500 ml.
Course of Calcium Stone Disease without Treatment. What Can We Expect?
TLDR
Renunciation of metaphylaxis is justified in first stone formers with idiopathic calcium oxalate and apatite stones, however, all patients should be advised to increase their fluid intake.
Factors Influencing the Course of Calcium Oxalate Stone Disease
TLDR
AP(CaOx) indexs and SAI were the most obvious predictors of the recurrence risk and these two variables might be useful for deriving an expected recurrencerisk at a defined point of time in a group of recurrent stone formers.
Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium stones.
TLDR
Long-term treatment with thiazides appears to be a safe and effective method for the prevention of recurrent calcium stones and reduces urinary calcium excretion in almost all patients irrespective of their initial urinary calcium level.
...
1
2
3
4
5
...